Novartis Inks $390M FCA Deal Over Pharmacy Discounts
By Jeff Overley ( October 27, 2015, 11:13 AM EDT) -- Novartis AG on Tuesday said it has tentatively agreed to shell out $390 million to end a whistleblower's False Claims Act suit alleging improper kickbacks to pharmacies to boost sales of several prescription drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.